Melanotan II: difference between revisions
Diff·revision 19 → 20·11:18, 16 Oct 2025
Difference between revision 19 and revision 20 of Melanotan II. 3 lines changed; the page grew by 275 bytes.
| Revision 19 — 16:02, 26 Sep 2025 TB500_Tarquin (talk) correct the residue numbering — the source numbers from the mature peptide 4,374 bytes ±0 | Revision 20 — 11:18, 16 Oct 2025 PuffRemoverPax (talk) add category for the peptide class 4,649 bytes +275 | ||
|---|---|---|---|
| 34 | Material sold as melanotan II is subject to the same documentary considerations as any research peptide. It is a short cyclic peptide and therefore a simpler synthesis than the incretin analogues, though cyclisation adds its own impurity possibilities. See [[Certificate of analysis]] and [[Peptide content]].{{r|usp1503}} | 34 | Material sold as melanotan II is subject to the same documentary considerations as any research peptide. It is a short cyclic peptide and therefore a simpler synthesis than the incretin analogues, though cyclisation adds its own impurity possibilities. See [[Certificate of analysis]] and [[Peptide content]].{{r|usp1503}} |
| 35 | 35 | ||
| + | 36 | This wiki does not represent it as suitable for human use, and nothing here is medical advice. See [[Research use only]].{{r|reports}} | |
| + | 37 | ||
| 36 | == References == | 38 | == References == |
| 37 | {{reflist}} | 39 | {{reflist}} |
| ⋮ | ⋮ | ||
| 40 | <ref name="cone2005">Cone RD. "Anatomy and regulation of the central melanocortin system." ''Nature Neuroscience'' 8(5):571–578 (2005). PMID 15856065.</ref> | 42 | <ref name="cone2005">Cone RD. "Anatomy and regulation of the central melanocortin system." ''Nature Neuroscience'' 8(5):571–578 (2005). PMID 15856065.</ref> |
| 41 | <ref name="usp1503">United States Pharmacopeia, General Chapter <1503>, ''Quality Attributes of Synthetic Peptide Drug Substances''.</ref> | 43 | <ref name="usp1503">United States Pharmacopeia, General Chapter <1503>, ''Quality Attributes of Synthetic Peptide Drug Substances''.</ref> |
| + | 44 | <ref name="reports">PeptidePedia Wiki community test-report tally, 2024–2026 (self-reported; see [[Project:Sourcing_guidelines]]).</ref> | |
| 42 | 45 | ||
| 43 | == See also == | 46 | == See also == |